aTyr Pharma Inc Stock Nasdaq
Equities
US0021201035
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 281K | Sales 2025 * | 7.46M | Capitalization | 109M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -60M | EV / Sales 2024 * | 390 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 14.7 x |
P/E ratio 2024 * |
-1.75
x | P/E ratio 2025 * |
-2.05
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.87% |
Latest transcript on aTyr Pharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 16-03-29 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 18-07-29 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 05-09-07 |
Tim Coughlin
CHM | Chairman | 57 | 17-04-09 |
John Clarke
BRD | Director/Board Member | 70 | 05-08-31 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |